SCHEMBL7780689

SCHEMBL7780689

CC#Cn1cc(-c2ccccc2)c(-c2ccc(S(C)(=O)=O)cc2)n1

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 13/20 0.51
PTGS1 P23219 2/20 0.51
ALOX5 P09917 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779734 0.90 PTGS2 (0.47) PTGS2PTGS1
SCHEMBL7780786 0.89 PTGS2 (0.50) PTGS2PTGS1
SCHEMBL7780029 0.89 PTGS2 (0.55) PTGS2PTGS1
SCHEMBL7780848 0.89 PTGS2 (0.49) PTGS2PTGS1
SCHEMBL7779985 0.86 PTGS2 (0.50) PTGS2PTGS1
SCHEMBL7780852 0.81 PTGS2 (0.47) PTGS2
SCHEMBL7779486 0.80 PTGS2 (0.58) PTGS2PTGS1ALOX5
SCHEMBL7772809 0.79 PTGS2 (0.58) PTGS2PTGS1
SCHEMBL7777652 0.79 CA9 (0.47) PTGS2PTGS1
SCHEMBL7780383 0.78 PTGS2 (0.50) PTGS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed